BG
ADAP

Bellevue Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Bellevue Group’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-131,135
Closed -$754K – 136
2018
Q4 		$754K Buy
131,135
+72,600
+124% +$417K 0.05% 124
2018
Q3 		$794K Sell
58,535
-1,400
-2% -$19K 0.05% 130
2018
Q2 		$711K Buy
+59,935
New +$711K 0.06% 128